(QUBT) Quantum Computing - Overview
Stock: Photonic Chip, Entropy Computer, Edge Reservoir, Quantum Authentication
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 121% |
| Relative Tail Risk | -16.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.47 |
| Alpha | -40.10 |
| Character TTM | |
|---|---|
| Beta | 2.249 |
| Beta Downside | 2.115 |
| Drawdowns 3y | |
|---|---|
| Max DD | 82.89% |
| CAGR/Max DD | 0.68 |
Description: QUBT Quantum Computing January 12, 2026
Quantum Computing Inc. (NASDAQ: QUBT) is an integrated-photonics firm that builds quantum hardware for U.S. commercial and government customers. Its product suite centers on thin-film lithium-niobate (LiNbO₃) chips that enable electro-optical modulators, frequency-conversion devices, and micro-ring resonator cavities. The company’s flagship “entropy quantum computer” delivers a full-stack solution that abstracts away low-level SDK development, exposing API-driven quantum-ready applications. Complementary offerings include a re-programmable reservoir-computing edge chip for recurrent neural-network workloads, a lidar system designed for high-visibility operation in fog, snow, ice or water, a quantum photonic vibrometer for remote vibration sensing, and quantum-network and authentication modules.
From a market perspective, the global quantum-hardware industry is projected to exceed $5 billion by 2028, driven by escalating U.S. federal R&D budgets (the 2023 National Quantum Initiative Act allocated $1.2 billion) and growing demand for secure communications. QUBT’s focus on LiNbO₃ photonics aligns with a sector-wide shift toward low-loss, high-bandwidth optical components, where average wafer yields have risen to ~85 % in 2024, improving unit economics. The company reported a 42 % year-over-year increase in R&D spend in Q2 2024, reflecting intensified competition from peers such as PsiQuantum and IonQ, which are also pursuing full-stack quantum solutions.
For a deeper quantitative view, you may explore the QUBT analyst dashboard on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income: -68.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.04 > 0.02 and ΔFCF/TA 23.45 > 1.0 |
| NWC/Revenue: 102.4k% < 20% (prev 341.4%; Δ 102.1k% < -1%) |
| CFO/TA -0.03 > 3% & CFO -23.1m > Net Income -68.4m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 154.9 > 1.5 & < 3 |
| Outstanding Shares: last quarter (166.8m) vs 12m ago 79.30% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 0.11% > 50% (prev 0.56%; Δ -0.45% > 0%) |
| Interest Coverage Ratio: -30.75 > 6 (EBITDA TTM -61.9m / Interest Expense TTM 2.15m) |
Altman Z'' -8.86
| A: 0.62 (Total Current Assets 562.8m - Total Current Liabilities 3.63m) / Total Assets 898.2m |
| B: -0.24 (Retained Earnings -217.6m / Total Assets 898.2m) |
| C: -0.14 (EBIT TTM -66.2m / Avg Total Assets 487.5m) |
| D: -10.71 (Book Value of Equity -217.6m / Total Liabilities 20.3m) |
| Altman-Z'' Score: -8.86 = D |
Beneish M -3.19
| DSRI: 1.06 (Receivables 491.0k/369.0k, Revenue 546.0k/433.7k) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.42 (AQ_t 0.36 / AQ_t-1 0.85) |
| SGI: 1.26 (Revenue 546.0k / 433.7k) |
| TATA: -0.05 (NI -68.4m - CFO -23.1m) / TA 898.2m) |
| Beneish M-Score: -3.19 (Cap -4..+1) = AA |
What is the price of QUBT shares?
Over the past week, the price has changed by -19.11%, over one month by -10.87%, over three months by -38.08% and over the past year by -7.30%.
Is QUBT a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the QUBT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 18 | 94.2% |
| Analysts Target Price | 18 | 94.2% |
| ValueRay Target Price | 9.5 | 2.9% |
QUBT Fundamental Data Overview January 25, 2026
P/B = 2.9258
Revenue TTM = 546.0k USD
EBIT TTM = -66.2m USD
EBITDA TTM = -61.9m USD
Long Term Debt = 1.94m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 641.0k USD (from shortTermDebt, last quarter)
Debt = 2.58m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -349.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.02b USD (2.57b + Debt 2.58m - CCE 555.6m)
Interest Coverage Ratio = -30.75 (Ebit TTM -66.2m / Interest Expense TTM 2.15m)
EV/FCF = -64.08x (Enterprise Value 2.02b / FCF TTM -31.5m)
FCF Yield = -1.56% (FCF TTM -31.5m / Enterprise Value 2.02b)
FCF Margin = -5760 % (FCF TTM -31.5m / Revenue TTM 546.0k)
Net Margin = -12.5k% (Net Income TTM -68.4m / Revenue TTM 546.0k)
Gross Margin = -372.2% ((Revenue TTM 546.0k - Cost of Revenue TTM 2.58m) / Revenue TTM)
Gross Margin QoQ = 32.81% (prev 42.62%)
Tobins Q-Ratio = 2.24 (Enterprise Value 2.02b / Total Assets 898.2m)
Interest Expense / Debt = 0.15% (Interest Expense 4000 / Debt 2.58m)
Taxrate = 0.0% (0.0 / 2.36m)
NOPAT = -66.2m (EBIT -66.2m * (1 - 0.00%)) [loss with tax shield]
Current Ratio = 154.9 (out of range, set to none) (Total Current Assets 562.8m / Total Current Liabilities 3.63m)
Debt / Equity = 0.00 (Debt 2.58m / totalStockholderEquity, last quarter 877.9m)
Debt / EBITDA = 5.65 (negative EBITDA) (Net Debt -349.9m / EBITDA -61.9m)
Debt / FCF = 11.12 (negative FCF - burning cash) (Net Debt -349.9m / FCF TTM -31.5m)
Total Stockholder Equity = 400.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -14.03% (Net Income -68.4m / Total Assets 898.2m)
RoE = -17.07% (Net Income TTM -68.4m / Total Stockholder Equity 400.5m)
RoCE = -16.46% (EBIT -66.2m / Capital Employed (Equity 400.5m + L.T.Debt 1.94m))
RoIC = -16.54% (negative operating profit) (NOPAT -66.2m / Invested Capital 400.5m)
WACC = 14.19% (E(2.57b)/V(2.57b) * Re(14.20%) + D(2.58m)/V(2.57b) * Rd(0.15%) * (1-Tc(0.0)))
Discount Rate = 14.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 29.56%
Fair Price DCF = unknown (Cash Flow -31.5m)
EPS Correlation: 37.46 | EPS CAGR: 176.0% | SUE: 0.44 | # QB: 0
Revenue Correlation: 53.65 | Revenue CAGR: 199.6% | SUE: 3.97 | # QB: 1
EPS next Quarter (2026-03-31): EPS=-0.04 | Chg30d=+0.010 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=-0.17 | Chg30d=+0.020 | Revisions Net=+1 | Growth EPS=+2.9% | Growth Revenue=+246.3%